Caspase inhibitors induce a switch from apoptotic to proinflammatory signaling in CD95-stimulated T lymphocytes

European Journal of Immunology

Volumn 32, Issue 9, 2002, Pages 2471-2480

  Scheller, Carsten ^a,b   Sopper, Sieghart ^a   Ehrhardt, Christina ^b   Flory, Egbert ^c   Chen, Peifeng ^b   Koutsilieri, Eleni ^a   Ludwig, Stephan ^b   Ter Meulen, Volker ^a   Jassoy, Christian ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c PAUL EHRLICH INSTITUT   (Germany)

Author keywords

Apoptosis; Benzyloxycarbonyl Val Ala Asp fluoromethyl ketone; Cytokines; Ile Glu Thr Asp fluoromethyl ketone; Necrosis; NF B

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE; CASPASE INHIBITOR; COLONY STIMULATING FACTOR 1; CYTOKINE; ENZYME INHIBITOR; FAS ANTIGEN; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KETONE DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; INFLAMMATION; MEDIATOR; NECROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

AMINO ACID CHLOROMETHYL KETONES; ANTIGENS, CD; ANTIGENS, CD95; APOPTOSIS; BUTADIENES; CELL LINE; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; HYDROGEN-ION CONCENTRATION; IMIDAZOLES; INFLAMMATION; INTERFERON TYPE II; MAP KINASE KINASE 1; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; NECROSIS; NF-KAPPA B; NITRILES; OLIGOPEPTIDES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PYRIDINES; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036739041     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200209)32:9<2471::AID-IMMU2471>3.0.CO;2-E     Document Type: Article

References (33)

1. Nagata, S. and Golstein, P., The Fas death factor. Science 1995. 267: 1449-1456.
2. Kischkel, F. C., Hellbardt, S., Behrmann, I., Germer, M., Pawlita, M., Krammer, P. H. and Peter, M. E., Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 1995. 14: 5579-5588.
3. Chinnaiyan, A. M., O'Rourke, K., Tewari, M. and Dixit, V. M., FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 1995. 81: 505-512.
4. Martin, S. J. and Green, D. R., Protease activation during apoptosis: death by a thousand cuts? Cell 1995. 82: 349-352.
5. Baud, V. and Karin, M., Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 2001. 11: 372-377.
6. Magnusson, C. and Vaux, D. L., Signalling by CD95 and TNF receptors: not only life and death. Immunol. Cell Biol. 1999. 77: 41-46.
7. Wallach, D., Varfolomeev, E. E., Malinin, N. L., Goltsev, Y. V., Kovalenko, A. V. and Boldin, M. P., Tumor necrosis factor receptor and Fas signaling mechanisms. Annu. Rev. Immunol. 1999. 17: 331-367.
8. Ponton, A., Clement, M. V. and Stamenkovic, I., The CD95 (APO-1/Fas) receptor activates NF-kappaB independently of its cytotoxic function. J. Biol. Chem. 1996. 271: 8991-8995.
9. Alderson, M. R., Armitage, R. J., Maraskovsky, E., Tough, T. W., Roux, E., Schooley, K., Ramsdell, F. and Lynch, D. H., Fas transduces activation signals in normal human T lymphocytes. J. Exp. Med. 1993. 178: 2231-2235.
10. Zhang, J., Cado, D., Chen, A., Kabra, N. H. and Winoto, A., Fas-mediated apoptosis and activation-induced T cell proliferation are defective in mice lacking FADD/Mort1. Nature 1998. 392: 296-300.
11. Kennedy, N. J., Kataoka, T., Tschopp, J. and Budd, R. C., Caspase activation is required for T cell proliferation. J. Exp. Med. 1999. 190: 1891-1896.
12. Alam, A., Cohen, L. Y., Aouad, S. and Sekaly, R. P., Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells. J. Exp. Med. 1999. 190: 1879-1890.
13. Vercammen, D., Brouckaert, G., Denecker, G., Van de Craen, M., Declercq, W., Fiers, W. and Vandenabeele, P., Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways. J. Exp. Med. 1998. 188: 919-930.
14. Lemaire, C., Andreau, K., Souvannavong, V. and Adam, A., Inhibition of caspase activity induces a switch from apoptosis to necrosis. FEBS Lett. 1998. 425: 266-270.
15. Holler, N., Zaru, R., Micheau, O., Thome, M., Attinger, A., Valitutti, S., Bodmer, J. L., Schneider, P., Seed, B. and Tschopp, J., Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat. Immunol. 2000. 1: 489-495.
16. Schulze-Osthoff, K., Krammer, P. H. and Droge, W., Divergent signalling via APO-1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death. EMBO J. 1994. 13: 4587-4596.
17. May, M. J. and Ghosh, S., Signal transduction through NF-kappa B. Immunol. Today 1998. 19: 80-88.
18. Hoffmeyer, A., Grosse-Wilde, A., Flory, E., Neufeld, B., Kunz, M., Rapp, U. R. and Ludwig, S., Different mitogen-activated protein kinase signaling pathways cooperate to regulate tumor necrosis factor alpha gene expression in T lymphocytes. J. Biol. Chem. 1999. 274: 4319-4327.
19. Davies, S. P., Reddy, H., Caivano, M. and Cohen, P., Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 2000. 351: 95-105.
20. Daum, G., Eisenmann-Tappe, I., Fries, H. W., Troppmair, J. and Rapp, U. R., The ins and outs of Raf kinases. Trends Biochem. Sci. 1994. 19: 474-480.
21. Natarajan, K., Singh, S., Burke, T. R., Jr., Grunberger, D. and Aggarwal, B. B., Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. Proc. Natl. Acad. Sci. USA 1996. 93: 9090-9095.
22. Klas, C., Debatin, K. M., Jonker, R. R. and Krammer, P. H., Activation interferes with the APO-1 pathway in mature human T cells. Int. Immunol. 1993. 5: 625-630.
23. Hartel, C., Bein, G., Muller-Steinhardt, M. and Kluter, H., Ex vivo induction of cytokine mRNA expression in human blood samples. J. Immunol. Methods 2001. 249: 63-71.
24. Kataoka, T., Budd, R. C., Holler, N., Thome, M., Martinon, F., Irmler, M., Burns, K., Hahne, M., Kennedy, N., Kovacsovics, M. and Tschopp, J., The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways. Curr. Biol. 2000. 10: 640-648.
25. Clemens, M. J., Bushell, M. and Morley, S. J., Degradation of eukaryotic polypeptide chain initiation factor (elF) 4G in response to induction of apoptosis in human lymphoma cell lines. Oncogene 1998. 17: 2921-2931.
26. Nadano, D. and Sato, T. A., Caspase-3-dependent and -independent degradation of 28 S ribosomal RNA may be involved in the inhibition of protein synthesis during apoptosis initiated by death receptor engagement. J. Biol. Chem. 2000. 275: 13967-13973.
27. Widmann, C., Gibson, S. and Johnson, G. L., Caspase-dependent cleavage of signaling proteins during apoptosis. A turn-off mechanism for anti-apoptotic signals. J. Biol. Chem. 1998. 273: 7141-7147.
28. Rensing-Ehl, A., Hess, S., Ziegler-Heitbrock, H. W., Riethmuller, G. and Engelmann, H., Fas/Apo-1 activates nuclear factor kappa B and induces interleukin-6 production. Inflammation 1995. 45: 161-174.
29. Rescigno, M., Piguet, V., Valzasina, B., Lens, S., Zubler, R., French, L., Kindler, V., Tschopp, J. and Ricciardi-Castagnoli, P., Fas engagement induces the maturation of dendritic cells (DCs), the release of interleukin (IL)-1beta, and the production of interferon gamma in the absence of IL-12 during DC-T cell cognate interaction: a new role for Fas ligand in inflammatory responses. J. Exp. Med. 2000. 192: 1661-1668.
30. Ashany, D., Savir, A., Bhardwaj, N. and Elkon, K. B., Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway. J. Immunol. 1999. 163: 5303-5311.
31. Scheller, C., Sopper, S., Chen, P., Flory, E., Koutsilieri, E., Racek, T., Ludwig, S., ter Meulen, V. and Jassoy, C., Caspase inhibition activates HIV in latently infected cells: role of tumor necrosis factor receptor 1 and CD95. J. Biol. Chem. 2002. 277: 15459-15464.
32. Folks, T. M., Clouse, K. A., Justement, J., Rabson, A., Duh, E., Kehrl, J. H. and Fauci, A. S., Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T cell clone. Proc. Natl. Acad. Sci. USA 1989. 86: 2365-8.
33. Flory, E., Weber, C. K., Chen, P., Hoffmeyer, A., Jassoy, C. and Rapp, U. R., Plasma membrane-targeted Raf kinase activates NF-kappaB and human immunodeficiency virus type 1 replication in T lymphocytes. J. Virol. 1998. 72: 2788-94.